Search Results for:

Sabinsa’s Curcumin C3 Complex® has been found by researchers in several studies to be an excellent complementary supplement to Omega-3 fatty acids. While curcumin is a well recognized anti-inflammatory agent, Omega-3 acids are known precursors of several biosynthetic inflammatory resolvers. Together C3 Complex® and Omega-3 acids work in tandem to bring about relief under situations where inflammation … Read more

Sabinsa Japan Corporation will host Sabinsa on Wheels, a day-long science summit for customers, on October 21, 2016 at the Shangri-La Hotel in Tokyo, Japan. The topics presented by a range of speakers will include the latest clinical studies conducted on Sabinsa’s proprietary dietary supplement ingredients. Sabinsa on Wheels will begin at 9:00 AM JST, … Read more

Sabinsa’s VP Scientific Affairs Anurag Pande PhD will give a presentation addressing the recent safety and efficacy studies on Sabinsa’s shelf-stable probiotic LactoSpore® at the Global Engage 4th Microbiome R&D And Business Collaboration Forum to be held in La Jolla, California October 3 – 4, 2016. Dr. Pande will also touch upon the clinical results on … Read more

Sabinsa Corporation’s parent company Sami Labs was recently honored with two Pharmexcil Awards for 2015 – 2016 in the Herbals category: the Silver Award for Patents and the Outstanding Export Performance Award. A ministry set up by the Government of India as a gateway to global pharma trade, Pharmexcil presents awards each year to salute those companies that demonstrate … Read more

Curry Powder To Clinical Significance Book Signed By Dr. Majeed Available In Booth # Y135 Throughout 2016 a number of clinical studies have been published on ingredients developed by Sabinsa Corporation, and many of those will be highlighted in the company’s booth, # Y135, at SupplySide West, October 6 –7, 2016 in Las Vegas, NV. … Read more

Sabinsa Corp. and Chemill Inc. (Bothell, WA) have reached an agreement which resolves a previous lawsuit for infringement of Sabinsa’s U.S. Patent No. 6,653,327, covering compositions and uses of turmeric-derived tetrahydrocurcuminoids. The matter has been settled on undisclosed terms. Chemill will respect the Patent as a due licensee. “We are pleased that this matter has … Read more

Sabinsa’s Curcumin C3 Complex® and Curcumin C3 Reduct® received two significant health claims from Health Canada based on the new clinical studies on the respective products. Curcumin C3 Complex®– Helps support healthy serum triglyceride levels Shortly after being chosen for NutraIngredients’s “Best University Research Award” for a clinical study done in Iran, Sabinsa’s Curcumin C3 Complex® received approval from … Read more

In line with its commitment to enforce intellectual property and to honour the trust of millions of customers vested in its branded ingredients, Sabinsa Corporation successfully defended its proprietary rights on European Union Community trademark. 000379743 for “Boswellin” in international class 05. The legal action was jointly initiated by Sabinsa Corporation, NJ, USA and its … Read more

Health Canada, the federal department that regulates the products that help the people of Canada maintain and improve their health, has issued a Product License to Sabinsa for a significant health claim on LactoSpore® Balance: “Helps relieve abdominal pain associated with IBS (Irritable Bowel Syndrome).” The strain is LactoSpore® MTCC 5856. “This health claim was based on the IBS clinical … Read more

Sami-Sabinsa, a research oriented Indian multinational health science company and a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals and probiotics, has been recognized with two awards in the Global Health & Pharma 2016 International Life Science Awards: Best International Life Science Company and Most Innovative Inflammatory Condition Treatment: Curcumin C3 Power Chewable Natural Immune … Read more